Overview

Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to establish an optimal monitoring regimen in NutropinAq treated children, using newly developed capillary blood spot IGF-1 measurement technology.
Phase:
Phase 3
Details
Lead Sponsor:
Ipsen